Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "X"

9431 News Found

Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery
R&D | April 15, 2026

Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery

The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners


Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure
Hospitals | April 15, 2026

Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure

Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform


Vetter ramps up global clinical manufacturing push with major US & Europe expansion
News | April 15, 2026

Vetter ramps up global clinical manufacturing push with major US & Europe expansion

The goal is to better support drug developers as programs move from laboratory research into clinical trials


NantBioRenewables expands US manufacturing footprint in Alabama
Biotech | April 15, 2026

NantBioRenewables expands US manufacturing footprint in Alabama

To boost compostable packaging, resin innovation, and supply chain speed


Bisleri expands CSR support for rural mental health programme in MP
Healthcare | April 15, 2026

Bisleri expands CSR support for rural mental health programme in MP

Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district


CDSCO invites bids for next-gen Digital Drugs Regulatory System
Drug Approval | April 15, 2026

CDSCO invites bids for next-gen Digital Drugs Regulatory System

API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India


Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies
R&D | April 15, 2026

Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies

The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio


FDA presses 2,200+ companies to fix missing clinical trial results
News | April 15, 2026

FDA presses 2,200+ companies to fix missing clinical trial results

Move amid evidence of widespread reporting gaps